Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 18;16(4):656-658.
doi: 10.18240/ijo.2023.04.22. eCollection 2023.

Refractory intraocular hypertension after dexamethasone-implant intravitreal injection treated with Preserflo MicroShunt implantation

Lucas Sejournet  1 , Amina Rezkallah  1 , Olivier Loria  1 , Laurent Kodjikian  1   2 , Thibaud Mathis  1   2 , Philippe Denis  1
Affiliations

Refractory intraocular hypertension after dexamethasone-implant intravitreal injection treated with Preserflo MicroShunt implantation

Lucas Sejournet et al. Int J Ophthalmol. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Ultrasound biomicroscopy of filtering bleb after Preserflo MicroShunt implantation.
Figure 2
Figure 2. IOP fluctuations over time with therapeutic adjustment
OHT: Ocular hypertension; IOP: Intraocular pressure.
See this image and copyright information in PMC

References

    1. Bellocq D, Pierre-Kahn V, Matonti F, et al. Effectiveness and safety of dexamethasone implants for postsurgical macular oedema including Irvine-Gass syndrome: the EPISODIC-2 study. Br J Ophthalmol. 2017;101(3):333–341. - PubMed
    1. Boyer DS, Yoon YH, Belfort R, Bandello F, Maturi RK, Augustin AJ, Li XY, Cui H, Hashad Y, Whitcup SM. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 2014;121(10):1904–1914. - PubMed
    1. Malclès A, Dot C, Voirin N, Vié AL, Agard É, Bellocq D, Denis P, Kodjikian L. Safety of intravitreal dexamethasone implant (ozurdex): the safodex study. incidence and risk factors of ocular hypertension. Retina. 2017;37(7):1352–1359. - PubMed
    1. Caprioli J, Kim JH, Friedman DS, Kiang T, Moster MR, Parrish RK, 2nd, Rorer EM, Samuelson T, Tarver ME, Singh K, Eydelman MB. Special commentary: supporting innovation for safe and effective minimally invasive glaucoma surgery: summary of a joint meeting of the American glaucoma society and the food and drug administration, Washington, DC, February 26, 2014. Ophthalmology. 2015;122(9):1795–1801. - PubMed
    1. Schlenker MB, Gulamhusein H, Conrad-Hengerer I, Somers A, Lenzhofer M, Stalmans I, Reitsamer H, Hengerer FH, Ahmed IIK. Efficacy, safety, and risk factors for failure of standalone ab interno gelatin microstent implantation versus standalone trabeculectomy. Ophthalmology. 2017;124(11):1579–1588. - PubMed

LinkOut - more resources